PEPSICO INC
Business
PEPSICO INC is a global beverage and convenient food company that makes, markets, distributes and sells branded snacks, beverages and related consumer products. Its main offerings include salty snacks and dips (e.g., Lay’s, Doritos, Cheetos, Sabra), beverages and concentrates (e.g., Pepsi, Mountain Dew, Gatorade, Aquafina, SodaStream) and Quaker-branded foods such as cereals and grains. The company reports operations across seven segments: Frito‑Lay North America, Quaker Foods North America, PepsiCo Beverages North America, Latin America, Europe, AMESA and APAC. It sells in more than 200 countries and territories through company operations, authorized bottlers, contract manufacturers, direct‑store‑delivery, distributor networks, customer warehouses and e‑commerce channels.
Summary from filing dated 2025-02-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net Revenue | 93,925 | 91,854 | 91,471 | 86,392 | 79,474 | |
| Cost of sales | 43,066 | 41,744 | 41,881 | 40,576 | 37,075 | |
| Gross profit | 50,859 | 50,110 | 49,590 | 45,816 | 42,399 | |
| Selling, general and administrative expenses | 37,368 | 37,190 | 36,677 | 34,459 | 31,237 | |
| Impairment of Intangible Assets (Excluding Goodwill) | 1,993 | 33 | 927 | 3,166 | 0 | |
| Operating Profit | 11,498 | 12,887 | 11,986 | 11,512 | 11,162 | |
| Other pension and retiree medical benefits (expense)/income | −133 | −22 | 250 | 132 | 522 | |
| Net interest expense and other | −1,121 | −919 | −819 | −939 | −1,863 | |
| Income before income taxes | 10,244 | 11,946 | 11,417 | 10,705 | 9,821 | |
| Provision for income taxes | 1,949 | 2,320 | 2,262 | 1,727 | 2,142 | |
| Net income | 8,295 | 9,626 | 9,155 | 8,978 | 7,679 | |
| Less: Net income attributable to noncontrolling interests | 55 | 48 | 81 | 68 | 61 | |
| Net Income Attributable to PepsiCo | 8,240 | 9,578 | 9,074 | 8,910 | 7,618 | |
| Basic (per share) | 6.02 | 6.97 | 6.59 | 6.45 | 5.51 | |
| Diluted (per share) | 6 | 6.95 | 6.56 | 6.42 | 5.49 | |
| Basic (shares) | 1,369 | 1,373 | 1,376 | 1,380 | 1,382 | |
| Diluted (shares) | 1,373 | 1,378 | 1,383 | 1,387 | 1,389 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 9,159 | 8,505 | 9,711 | 4,954 | 5,596 | |
| Short-term Investments | 371 | 761 | 292 | 394 | 392 | |
| Accounts and notes receivable, net | 11,506 | 10,333 | 10,815 | 10,163 | 8,680 | |
| Inventories | 5,845 | 5,306 | 5,334 | 5,222 | 4,347 | |
| Prepaid expenses and other current assets | 1,068 | 921 | 798 | 806 | 980 | |
| Assets, Current | 27,949 | 25,826 | 26,950 | 21,539 | 21,783 | |
| Property, Plant and Equipment, net | 29,905 | 28,008 | 27,039 | 24,291 | 22,407 | |
| Amortizable Intangible Assets, net | 1,219 | 1,102 | 1,199 | 1,277 | 1,538 | |
| Goodwill | 18,916 | 17,534 | 17,728 | 18,202 | 18,381 | |
| Indefinite-lived Intangible Assets (Excluding Goodwill) | 13,847 | 13,699 | 13,730 | 14,309 | 17,127 | |
| Equity Method Investments | 2,038 | 1,985 | 2,714 | 3,073 | 2,350 | |
| Deferred Income Tax Assets, Net | 4,541 | 4,362 | 4,474 | 4,204 | 4,310 | |
| Other Assets | 8,984 | 6,951 | 6,661 | 5,292 | 4,481 | |
| Total Assets | 107,399 | 99,467 | 100,495 | 92,187 | 92,377 | |
| Short-term debt obligations | 6,861 | 7,082 | 6,510 | 3,414 | 4,308 | |
| Accounts payable and other current liabilities | 25,903 | 24,454 | 25,137 | 23,371 | 21,159 | |
| Liabilities, Current | 32,764 | 31,536 | 31,647 | 26,785 | 26,220 | |
| Long-Term Debt Obligations | 42,321 | 37,224 | 37,595 | 35,657 | 36,026 | |
| Deferred Income Tax Liabilities, Net | 3,802 | 3,484 | 3,895 | 4,133 | 4,826 | |
| Other Liabilities, Noncurrent | 7,965 | 9,052 | 8,721 | 8,339 | 9,154 | |
| Liabilities | 86,852 | 81,296 | 81,858 | 74,914 | 76,226 | |
| Commitments and contingencies | — | — | — | — | — | |
| Common stock, authorized | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | |
| Common stock, issued | 1,367 | 1,372 | 1,374 | 1,377 | 1,383 | |
| Common stock, par value 12/3 per share (authorized 3,600 shares, issued, net of repurchased common stock at par value: 1,380 and 1,391 shares, respectively) | 23 | 23 | 23 | 23 | 23 | |
| Additional Paid in Capital, Common Stock | 4,451 | 4,385 | 4,261 | 4,134 | 4,001 | |
| Retained Earnings (Accumulated Deficit) | 72,788 | 72,266 | 70,035 | 67,800 | 65,165 | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | −15,024 | −17,612 | −15,534 | −15,302 | −14,898 | |
| Treasury Stock, Common, Shares | 500 | 495 | 493 | 490 | — | |
| Treasury Stock, Value | −41,832 | −41,021 | −40,282 | −39,506 | −38,248 | |
| Stockholders' Equity Attributable to Parent | 20,406 | 18,041 | 18,503 | 17,149 | 16,043 | |
| Stockholders' Equity Attributable to Noncontrolling Interest | 141 | 130 | 134 | 124 | 108 | |
| Total Equity | 20,547 | 18,171 | 18,637 | 17,273 | 16,151 | |
| Liabilities and Equity | 107,399 | 99,467 | 100,495 | 92,187 | 92,377 | |
| Other Investments | 2,526 | 1,346 | 1,616 | 813 | 277 | |
| Accounts Receivable, Allowance for Credit Loss, Current | 230 | 356 | 175 | 150 | 147 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 3,451 | 3,160 | 2,948 | 2,763 | 2,710 | |
| Impairment and other charges | 1,946 | 714 | 1,230 | 3,618 | 0 | |
| Product recall-related impact | 0 | 187 | 136 | 0 | 0 | |
| Payments for product recall-related impact | −6 | −148 | 0 | 0 | — | |
| Operating lease right-of-use asset amortization | 727 | 655 | 570 | 517 | 505 | |
| Share-based compensation expense | 288 | 362 | 380 | 343 | 301 | |
| Restructuring Charges | 983 | 727 | 445 | 411 | 247 | |
| Cash payments for restructuring charges | −796 | −436 | −434 | −224 | −256 | |
| Pension and retiree medical plan expenses | 504 | 414 | 150 | 419 | 123 | |
| Pension and retiree medical plan contributions | −472 | −348 | −410 | −384 | −785 | |
| Deferred income taxes and other tax charges and credits | 71 | −42 | −271 | −873 | 298 | |
| Tax payments related to the TCJ Act | −772 | −579 | −309 | −309 | −309 | |
| Accounts and notes receivable | −580 | −138 | −793 | −1,763 | −651 | |
| Inventories | −150 | −314 | −261 | −1,142 | −582 | |
| Prepaid expenses and other current assets | 195 | 40 | −13 | 118 | 159 | |
| Accounts payable and other current liabilities | −677 | −943 | 420 | 1,842 | 1,762 | |
| Income taxes payable | −433 | −123 | 310 | 57 | 30 | |
| Other, net | −712 | −311 | 189 | −325 | 375 | |
| Net Cash Provided by Operating Activities | 12,087 | 12,507 | 13,442 | 10,811 | 11,616 | |
| Capital spending | −4,415 | −5,318 | −5,518 | −5,207 | −4,625 | |
| Sales of property, plant and equipment | 528 | 342 | 198 | 251 | 166 | |
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | −3,391 | −256 | −314 | −873 | −61 | |
| Divestitures, sales of investments in noncontrolled affiliates and other assets | 39 | 166 | 75 | 49 | 169 | |
| More than three months - purchases | −190 | −425 | −555 | −291 | 0 | |
| More than three months - maturities | 605 | 0 | 556 | 150 | 1,135 | |
| More than three months - Sales | 0 | 0 | 12 | 0 | 0 | |
| Three months or less, net | 45 | 5 | 3 | 24 | −58 | |
| Other investing, net | −100 | 14 | 48 | 11 | 5 | |
| Net Cash Used for Investing Activities | −6,879 | −5,472 | −5,495 | −2,430 | −3,269 | |
| Proceeds from issuances of long-term debt | 8,189 | 4,042 | 5,482 | 3,377 | 4,122 | |
| Payments of long-term debt | −4,082 | −3,886 | −3,005 | −2,458 | −3,455 | |
| More than three months - proceeds | 6,391 | 5,786 | 5,428 | 1,969 | 8 | |
| More than three months - payments | −7,920 | −5,639 | −3,106 | −1,951 | −397 | |
| Three months or less, net | 1,170 | 392 | −29 | −31 | 434 | |
| Cash dividends paid | −7,638 | −7,229 | −6,682 | −6,172 | −5,815 | |
| Share repurchases - common | −1,000 | −1,000 | −1,000 | −1,500 | −106 | |
| Proceeds from exercises of stock options | 97 | 166 | 116 | 138 | 185 | |
| Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | −113 | −135 | −140 | −107 | −92 | |
| Other financing | −73 | −53 | −73 | −72 | −47 | |
| Net Cash Used for Financing Activities | −4,979 | −7,556 | −3,009 | −8,523 | −10,780 | |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 422 | −687 | −277 | −465 | −114 | |
| Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash | 651 | −1,208 | 4,661 | −607 | −2,547 | |
| Acquisition and divestiture-related charges | 453 | 22 | 41 | 80 | −4 | |
| Payments for Merger Related Costs | −228 | −18 | −41 | −46 | −176 |